Artículos relacionados a Real-World Evidence in Drug Development and Evaluation...
Real-World Evidence in Drug Development and Evaluation (Chapman & Hall/CRC Biostatistics Series) - Tapa dura
Sinopsis
Real-world evidence (RWE) has been at the forefront of pharmaceutical innovations. It plays an important role in transforming drug development from a process aimed at meeting regulatory expectations to an operating model that leverages data from disparate sources to aid business, regulatory, and healthcare decision making. Despite its many benefits, there is no single book systematically covering the latest development in the field.
Written specifically for pharmaceutical practitioners, Real-World Evidence in Drug Development and Evaluation, presents a wide range of RWE applications throughout the lifecycle of drug product development. With contributions from experienced researchers in the pharmaceutical industry, the book discusses at length RWE opportunities, challenges, and solutions.
Features
- Provides the first book and a single source of information on RWE in drug development
- Covers a broad array of topics on outcomes- and value-based RWE assessments
- Demonstrates proper Bayesian application and causal inference for real-world data (RWD)
- Presents real-world use cases to illustrate the use of advanced analytics and statistical methods to generate insights
- Offers a balanced discussion of practical RWE issues at hand and technical solutions suitable for practitioners with limited data science expertise
"Sinopsis" puede pertenecer a otra edición de este libro.
Acerca del autor
Harry Yang, Ph.D., is Vice President and Head of Biometrics at Fate Therapeutics. He has 25 years of experience across all aspects of drug research and development, from early target discovery, through pre-clinical, clinical, and CMC programs to regulatory approval and post-approval lifecycle management. He has published 7 statistical books, 15 book chapters, and over 90 peer-reviewed papers on diverse scientific and statistical subjects. He is a frequent invited speaker at national and international conferences. He also developed statistical courses and conducted training at the FDA and USP.
Binbing Yu, Ph.D., is Associate Director in the Oncology Statistical Innovation group at AstraZeneca. He serves as the statistical expert across the whole spectrum of drug R&D, including drug discovery, clinical trials, operation and manufacturing, clinical pharmacology, oncology medical affairs and post-marketing surveillance. He obtained his PhD in Statistics from the George Washington University. His primary research interests are clinical trial design and analysis, cancer epidemiology, causal inference in observation studies, PKPD modeling and Bayesian analysis.
"Sobre este título" puede pertenecer a otra edición de este libro.
- EditorialChapman & Hall
- Año de publicación2021
- ISBN 10 036702621X
- ISBN 13 9780367026219
- EncuadernaciónTapa dura
- IdiomaInglés
- Número de edición1
- Número de páginas190
- EditorYang Harry, Yu Binbing
- Contacto del fabricanteno disponible
EUR 157,68
EUR 17,23 gastos de envío desde Estados Unidos de America a España
Destinos, gastos y plazos de envíoComprar nuevo
Ver este artículo
EUR 138,18
EUR 9,33 gastos de envío desde Reino Unido a España
Destinos, gastos y plazos de envío
Resultados de la búsqueda para Real-World Evidence in Drug Development and Evaluation...
Imagen de archivo
REALWORLD EVIDENCE IN DRUG DEVELOPMENT &
Librería: Speedyhen, London, Reino Unido
Calificación del vendedor: 5 de 5 estrellas
Condición: NEW. Nº de ref. del artículo: NW9780367026219
Cantidad disponible: 2 disponibles
Imagen del vendedor
Real-World Evidence in Drug Development and Evaluation
Librería: GreatBookPricesUK, Woodford Green, Reino Unido
Calificación del vendedor: 5 de 5 estrellas
Condición: New. Nº de ref. del artículo: 38541738-n
Cantidad disponible: 10 disponibles
Imagen de archivo
Real-World Evidence in Drug Development and Evaluation (Chapman & Hall/CRC Biostatistics Series)
Librería: Ria Christie Collections, Uxbridge, Reino Unido
Calificación del vendedor: 5 de 5 estrellas
Condición: New. In. Nº de ref. del artículo: ria9780367026219_new
Cantidad disponible: 2 disponibles
Imagen de archivo
Real-World Evidence in Drug Development and Evaluation
Librería: THE SAINT BOOKSTORE, Southport, Reino Unido
Calificación del vendedor: 5 de 5 estrellas
Hardback. Condición: New. New copy - Usually dispatched within 4 working days. 720. Nº de ref. del artículo: B9780367026219
Cantidad disponible: 1 disponibles
Imagen del vendedor
Real-World Evidence in Drug Development and Evaluation
Publicado por
Chapman and Hall/CRC, 2021
ISBN 10: 036702621X
ISBN 13: 9780367026219
Antiguo o usado
Tapa dura
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
Calificación del vendedor: 5 de 5 estrellas
Condición: As New. Unread book in perfect condition. Nº de ref. del artículo: 38541738
Cantidad disponible: 10 disponibles
Imagen del vendedor
Real-World Evidence in Drug Development and Evaluation
Publicado por
Chapman and Hall/CRC, 2021
ISBN 10: 036702621X
ISBN 13: 9780367026219
Antiguo o usado
Tapa dura
Librería: GreatBookPricesUK, Woodford Green, Reino Unido
Calificación del vendedor: 5 de 5 estrellas
Condición: As New. Unread book in perfect condition. Nº de ref. del artículo: 38541738
Cantidad disponible: 10 disponibles
Imagen de archivo
Real-World Evidence in Drug Development and Evaluation (Chapman & Hall/CRC Biostatistics Series)
Librería: Majestic Books, Hounslow, Reino Unido
Calificación del vendedor: 5 de 5 estrellas
Condición: New. Nº de ref. del artículo: 380592427
Cantidad disponible: 3 disponibles
Imagen del vendedor
Real-World Evidence in Drug Development and Evaluation
Publicado por
Taylor & Francis Ltd Mär 2021, 2021
ISBN 10: 036702621X
ISBN 13: 9780367026219
Nuevo
Tapa dura
Librería: AHA-BUCH GmbH, Einbeck, Alemania
Calificación del vendedor: 5 de 5 estrellas
Buch. Condición: Neu. Neuware - This book concerns use of real world data (RWD) and real world evidence (RWE) to aid drug development across product cycle. RWD are healthcare data that are collected outside the constraints of conventual controlled randomized trials (CRTs); whereas RWE is the knowledge derived from aggregation and analysis of RWD. Nº de ref. del artículo: 9780367026219
Cantidad disponible: 2 disponibles
Imagen de archivo
Real-World Evidence in Drug Development and Evaluation
Publicado por
Taylor & Francis Ltd, 2021
ISBN 10: 036702621X
ISBN 13: 9780367026219
Nuevo
Tapa dura
Original o primera edición
Librería: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlanda
Calificación del vendedor: 5 de 5 estrellas
Condición: New. 2021. 1st Edition. Hardcover. . . . . . Nº de ref. del artículo: V9780367026219
Cantidad disponible: 2 disponibles
Imagen del vendedor
Real-World Evidence in Drug Development and Evaluation
Librería: moluna, Greven, Alemania
Calificación del vendedor: 5 de 5 estrellas
Gebunden. Condición: New. Harry Yang, Ph.D., is Vice President and Head of Biometrics at Fate Therapeutics. He has 25 years of experience across all aspects of drug research and development, from early target discovery, through pre-clinical, clinical, and CMC pro. Nº de ref. del artículo: 395875131
Cantidad disponible: 2 disponibles